【24h】

BIOKINETICS AND EFFECTS OF NANOPARTICLES

机译:纳米颗粒的生物动力学和作用

获取原文
获取原文并翻译 | 示例

摘要

Exposures to airborne nanosized particles (< 100 nm) have been experienced by humans throughout their evolutionary stages. Recently, the rapidly developing field of nanotechnology is likely to become yet another source for human exposures to nanosized particles - engineered nanoparticles (NPs) - by different routes, I.e., inhalation, ingestion, dermal, or even injection. Nanotechnology is defined as research and technology development at the atomic, molecular, or macromolecular levels, in the length scale of ~1 - 100 nm range. One of the many promising applications of engineered NPs is in the area of medicine, for example, targeted drug delivery as aerosols and to tissues which are difficult to reach. The discipline of nanomedicine has arisen to develop, test, and optimize these applications. However, the same properties that makes NP attractive for development in nanomedicine and for specific industrial processes could also prove deleterious when NP interact with cells. An emerging discipline - nanotoxicology, which can be defined as safety evaluation of engineered nanostructures and nanodevices - is gaining increased attention. Nanotoxicology research will not only provide information for risk assessment of NP based on data for hazard identification, dose-response relationships, and biokinetics, but will also help to advance further the field of nanomedicine by providing information to alter undesirable NP properties. Although potential adverse effects of engineered NP have not been systematically investigated, there are a number of studies in the area of inhalation toxicology and also human epidemiology from which some preliminary conclusions about effects of nanosized particles can be drawn. There are also some decades-old - mostly forgotten - studies with nanosized particles which shed light on the biokinetics of such particles once introduced into the organism. This presentation summarizes results of studies with nanosized particles with a focus on the respiratory tract and skin as portals of entry.
机译:人类在整个进化阶段都经历过空气中纳米颗粒(<100 nm)的暴露。近来,快速发展的纳米技术领域很可能会成为人类通过不同途径,即吸入,摄入,皮肤甚至注射而暴露于纳米颗粒的另一个来源,即工程化纳米颗粒(NPs)。纳米技术被定义为在原子,分子或大分子水平上的研究和技术开发,其长度范围为〜1-100 nm。工程化NP的许多有前途的应用之一是在医学领域,例如,作为气雾剂的靶向药物递送和难以到达的组织。纳米医学的学科已经出现,以开发,测试和优化这些应用程序。但是,当NP与细胞相互作用时,使NP吸引纳米药物开发和特定工业过程的相同特性也可能有害。新兴的学科-纳米毒理学,可以定义为工程纳米结构和纳米器件的安全性评估-受到越来越多的关注。纳米毒理学研究不仅将基于危害识别,剂量反应关系和生物动力学数据提供NP风险评估信息,而且还将通过提供改变不良NP特性的信息来帮助进一步推进纳米医学领域。尽管尚未对工程化NP的潜在不利影响进行系统研究,但在吸入毒理学和人类流行病学领域已有许多研究,可从中得出有关纳米粒子作用的一些初步结论。纳米粒子的研究也已有数十年之久,但大多被人们遗忘了,这些研究揭示了这种粒子一旦被引入生物体内的生物动力学。本演讲总结了纳米颗粒的研究结果,重点是呼吸道和皮肤作为入口。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号